Market Place
Sourcing Support
Gilead Wins HIV Patent Suit, Nabs Oncology and Inflammation Startup
11 May 2023 //
BIOSPACE
Gilead can`t escape antitrust suit centered on Cipla deal
23 Aug 2022 //
FIERCEPHARMA
Antios hep B drug slows viral rebound, but FDA hold casts shadow
27 Jun 2022 //
FIERCEBIOTECH
Antios` ATI-2173 Demonstrates Suppression of Hepatitis B Virus in PIIa Study
25 Jun 2022 //
PRNEWSWIRE
Hetero Labs`s Generic Emtricitabine; Tenofovir Receives Approval in the US
07 Oct 2021 //
FDA
Gilead, Merck and others slapped with `pay-for-delay` lawsuits
25 Sep 2021 //
FIERCEPHARMA
Lupin`s Generic Emtricitabine; Tenofovir DF Receives Approval In US
04 Jun 2021 //
FDA
Apotex`s Generic Emtricitabine Receives Approval in US
20 Apr 2021 //
FDA
Strides receives USFDA approval Emtricitabine & Tenofovir Disoproxil Fumarate
15 Jan 2021 //
BUSINESS-STANDARD
Common HIV drugs increase a type of immunity in the gut
23 Sep 2020 //
NEWSWIRE
ViiV HIV prevention trial stopped early on efficacy
18 May 2020 //
PHARMA TIMES
Zydus receives final approval from the USFDA for Emtricitabine & Tenofovir
04 Mar 2020 //
EQUITYBULLS
Gilead Claims Truvada Patents in HHS’ Complaint are Invalid
25 Jan 2020 //
RAPS
Facebook yanks HIV lawsuit ads after protest, fact check
02 Jan 2020 //
FIERCE PHARMA
Gilead’s converting Truvada PrEP users to Descovy faster than expected
03 Dec 2019 //
FIERCE PHARMA
Vemlidy tackles hep B in late-stage trials
14 Nov 2019 //
PHARMA TIMES
AHF Calls on Gilead for Major Price Cut on PrEP Drug Descovy
05 Oct 2019 //
BUSINESSWIRE
Merck`s Big Week: HIV Approval and Landmark 3-Country Approval for Keytruda
20 Sep 2019 //
BIOSPACE
FDA Action Alert: Merck and Amarin
16 Sep 2019 //
BIOSPACE
Gilead and Lyndra Team Up to Develop Long-Acting HIV Therapies
10 Jul 2019 //
BIOSPACE
FDA Eliminates REMS for HIV Drug Truvada and its Generics
03 Jul 2019 //
RAPS
FDA Plots Shift Away From CSR Pilot to Forge New Transparency on Drug Approval
27 Jun 2019 //
RAPS
HIV Drug `Truvada` Costs $2,000 In US, Only $8 In Australia
16 May 2019 //
IBTIMES
Tension over generic entry sees Gilead donating 2.4m bottles of PrE
15 May 2019 //
IN-PHARMATECHNOLOGIST
Gilead tries—and fails—to bail out of HIV drug safety lawsuit
14 May 2019 //
FIERCE PHARMA
Stribild (elvitegravir) Japan Tobacco v. Mylan Pharma
29 Jan 2019 //
PATENT LITIGATION
Yale Researchers Discover Protein in the Immune System Can Help Suppress HIV
22 Jan 2019 //
BIOSPACE
Truvada (emtricitabine, tenofovir disoproxil fumarate) : Gilead vs. Zydus
15 Jan 2019 //
PATENT LITIGATION
DOJ tells Supreme Court it has lost interest in its Gilead whistleblower case
04 Dec 2018 //
FIERCE PHARMA
Mylan Pharm`s Generic Tenofovir Disoproxil Fumarate Receives Approval in US
28 Nov 2018 //
FDA
Mylan Pharms` Generic Tenofovir Disoproxil Fumarate Receives Approval in US
27 Nov 2018 //
FDA
South Africa`s Aspen launches three-in-one HIV drug
26 Nov 2018 //
ECONOMIC TIMES
Gilead Sued For Intentionally Withholding Safer HIV Drug
15 Nov 2018 //
PR NEWSWIRE
Laurus Labs transfers new drug application to CASI Pharma
23 Oct 2018 //
HINDU BUSINESS LINE
Merck Announces Week 96 Data from Delstrigo for HIV-1
04 Oct 2018 //
BUSINESSWIRE
Merck’s HIV Therapy Delstrigo Meets Primary Efficacy Endpoint
04 Oct 2018 //
BUSINESSWIRE
CHMP puts 13 therapies forward for EU approval
24 Sep 2018 //
PHARMA TIMES
ViiV submits two-drug regimen for HIV in Europe
14 Sep 2018 //
PHARMA TIMES
FDA approves two new HIV drugs from Merck
31 Aug 2018 //
REUTERS
FDA Approves Merck’s DELSTRIGO Tablet as a Complete Regimen and PIFELTRO™
31 Aug 2018 //
BUSINESSWIRE
WHO Prequalifies Sun Pharma`s Tenofovir Disoproxil Fumerate API
23 Aug 2018 //
WHO EXTRANET
Apotex`s Generic Tenofovir Disoproxil Fumarate Receives Approval in US
31 Jul 2018 //
FDA
ContraVir Pharmaceuticals to Present at Virtual Investor Conference
05 Jul 2018 //
PR NEWSWIRE
ContraVir Announces the Approval of the IND & Initiation CRV431 in the US
14 Jun 2018 //
PRESS RELEASE
Check out the new generics approved for commercialization in Brazil
23 Apr 2018 //
ANVISA
FDA Gives Mylan’s New HIV Drug a Thumbs-Up
28 Mar 2018 //
BIOSPACE
Antiviral drug not beneficial for reducing mother-child transmission hepB
08 Mar 2018 //
NIG
Qilu Tianhe Generic Tenofovir Disoproxil Fumarate Receives Approval in US
07 Mar 2018 //
FDA
Laurus Labs Generic Tenofovir Disoproxil Fumarate Receives Approval In US
28 Feb 2018 //
FDA
ContraVir`s Announces TXL™ Has Been Granted Orphan Drug Designation
22 Feb 2018 //
PRESS RELEASE
Truvada® (emtricitabine & tenofovir disoproxil fumarate)elvitegravir, GS 9350 (cobicistat): ViiV Healthcare v. Gilead Sciences
07 Feb 2018 //
PATENT LITIGATION
